Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2023-07-19 00:00:00 ET · period of report 2023-07-18 · accession 0001209191-23-042798 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-07-19 | 2023-07-18+ | RXRX | Secora Michael | CFO | M - OptEx | $2.22 | +75.0K | 855.4K | +10% | +$166.5K |
| DM | 2023-07-19 | 2023-07-18+ | RXRX | Secora Michael | CFO | S - Sale+OE | $14.58 | -50.0K | 830.9K | -6% | -$729.0K |
| DM | 2023-07-19 | 2023-07-18+ | RXRX | Secora Michael | CFO | M - OptEx | $0.00 | -75.0K | 670.3K | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-07-19 | M | A | 37,500 | $2.22 | 867,913 | D | — | — | |
| 2 | Common | Class A Common Stock | 2023-07-19 | S | D | 1,991 | $14.36 | 865,922 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $13.78 to $14.76. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 3 | Common | Class A Common Stock | 2023-07-19 | S | D | 13,150 | $15.36 | 852,772 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $14.78 to $15.77. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 4 | Common | Class A Common Stock | 2023-07-18 | S | D | 500 | $14.05 | 830,413 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $14.01 to $14.09. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 5 | Common | Class A Common Stock | 2023-07-19 | S | D | 9,859 | $16.00 | 842,913 | D | — | — | (F6) This transaction was executed in multiple trades at prices ranging from $15.78 to $16.66. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 6 | Common | Class A Common Stock | 2023-07-18 | S | D | 24,500 | $13.62 | 830,913 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $13.00 to $13.99. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 7 | Common | Class A Common Stock | 2023-07-18 | M | A | 37,500 | $2.22 | 855,413 | D | — | — | |
| 8 | Derivative | Stock Option (Right to Buy) | 2023-07-18 | M | D | 37,500 | $0.00 | 707,813 | D | $2.22 · — to 2030-03-03 | 37,500 Class A Common Stock | (F7) The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the award shall vest one month after March 1, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date. |
| 9 | Derivative | Stock Option (Right to Buy) | 2023-07-19 | M | D | 37,500 | $0.00 | 670,313 | D | $2.22 · — to 2030-03-03 | 37,500 Class A Common Stock | (F7) The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the award shall vest one month after March 1, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date. |